HemoGenyx Pharmaceuticals Cash from Financing (Quarterly) Insights

HemoGenyx Pharmaceuticals Plc (HOPHF)

2.33 0.00 (0.00%) USD | OTCM | Aug 28, 16:00

Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for HOPHF.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cash from Financing (Quarterly) Chart

Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to . Start Trial.

Date	Value

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks

Start Trial

Silence Therapeutics Plc	0.002M
Biodexa Pharmaceuticals Plc	--
NuCana Plc	0.0685M
Mereo BioPharma Group Plc	0.00
Compass Pathways Plc	8.097M

Cash from Financing (Quarterly) Related Metrics

Free Cash Flow	-4.621M
Free Cash Flow Yield	-41.42%